Evidence of Non-Standard Material Matrices

Geopolymer-Based Nanoplatform for Targeted Delivery in Glioblastoma Therapy: A Technical Protocol

Abstract

This study investigates the application of aluminosilicate-based geopolymer matrices, characterized by specific crystalline fingerprints (XRD) and elemental stability (XRF), as a novel therapeutic delivery system for brain tumors. The study proposes a biocompatible, controlled-release protocol utilizing the unique pore-engineering capabilities of geopolymer structures.

1. Methodology & Material Properties

Mineral Composition (XRF): Optimized silicate/aluminate ratio for bio-stability.

Structural Architecture (XRD): Precisely engineered pore geometry at the nanometer scale, designed for targeted drug encapsulation and localized release within the blood-brain barrier (BBB) environment.

2. Proposed Therapeutic Protocol

Encapsulation: Loading of therapeutic agents into the geopolymer nanopores.

Targeting: Utilization of surface-modified geopolymer particles to bypass the BBB.

Release Mechanism: Passive/Active diffusion controlled by the material’s structural integrity.

3. References & Preceding Documentation

This research builds upon the following documented milestones:

10.5281/zenodo.20650359

10.5281/zenodo.20650360

10.5281/zenodo.20650361